negative impacts of glp 1 The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions Side Effects: Endocrine Society Journals

High obesity prevalence, expanding cardiovascular indications, recent oral formulation approvals, and intensifying competition between semaglutide and tirzepatide are supporting U.S

People with a BMI below 27 need further clinical evaluation to determine if a GLP-1 medication is appropriate for them

GLP-1 receptor agonists (like semaglutide, sold as Ozempic or Rybelsus) work by mimicking a gut hormone that helps regulate blood sugar, suppress appetite, and promote weight loss

Even though the product includes cane sugar, which is typically less sweet than sweeteners like stevia and sucralose, there are 10 grams per serving